These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 8348856)
1. Prokinetic agents for lower gastrointestinal motility disorders. Longo WE; Vernava AM Dis Colon Rectum; 1993 Jul; 36(7):696-708. PubMed ID: 8348856 [TBL] [Abstract][Full Text] [Related]
2. The current status of gastric prokinetic drugs. Schapira M; Henrion J; Heller FR Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914 [TBL] [Abstract][Full Text] [Related]
3. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Wiseman LR; Faulds D Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617 [TBL] [Abstract][Full Text] [Related]
4. Prokinetic agents: a key in the future of gastroenterology. Reynolds JC Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal motility disorders and gastrointestinal prokinetic therapy. Washabau RJ Vet Clin North Am Small Anim Pract; 2003 Sep; 33(5):1007-28, vi. PubMed ID: 14552159 [TBL] [Abstract][Full Text] [Related]
6. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders. Tack J; Coremans G; Janssens J Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013 [TBL] [Abstract][Full Text] [Related]
7. Domperidone: a peripherally acting dopamine2-receptor antagonist. Barone JA Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535 [TBL] [Abstract][Full Text] [Related]
8. Prokinetics in the Management of Functional Gastrointestinal Disorders. Quigley EMM Curr Gastroenterol Rep; 2017 Sep; 19(10):53. PubMed ID: 28887755 [TBL] [Abstract][Full Text] [Related]
9. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility. Scarpignato C; Pelosini I Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210 [TBL] [Abstract][Full Text] [Related]
10. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. McCallum RW; Prakash C; Campoli-Richards DM; Goa KL Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057 [TBL] [Abstract][Full Text] [Related]
11. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease. Ramirez B; Richter JE Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981 [TBL] [Abstract][Full Text] [Related]
12. Drugs coordinating and restoring gastrointestinal motility and their effect on selected hypodynamic gastrointestinal disorders in horses and cattle. Steiner A; Roussel AJ Zentralbl Veterinarmed A; 1995 Dec; 42(10):613-31. PubMed ID: 8822186 [TBL] [Abstract][Full Text] [Related]
14. [The potentials of erythromycin derivatives in the treatment of gastrointestinal motility disorders]. Peeters TL Z Gesamte Inn Med; 1991 Aug; 46(10-11):349-54. PubMed ID: 1926941 [TBL] [Abstract][Full Text] [Related]
17. Role of prokinetic drugs for treatment of postoperative ileus in the horse. Dart AJ; Hodgson DR Aust Vet J; 1998 Jan; 76(1):25-31. PubMed ID: 9578763 [TBL] [Abstract][Full Text] [Related]
18. [Pharmacologic treatments of transit disorders]. Manz M; Meier R Ther Umsch; 2007 Apr; 64(4):227-32. PubMed ID: 17663210 [TBL] [Abstract][Full Text] [Related]
19. Use of prokinetic agents in special populations. Horn JR Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacologic and clinical differentiation of prokinetic drugs]. May B; Greving I Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]